Financial Advisors, LLC Bristol Myers Squibb CO Transaction History

Financial Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$48.48 - $57.85 $25,306 - $30,197	522 Added 15.1%	3,979 $204,000
Q3 2023 Oct 10, 2023	SELL	$57.89 - $64.73 $57,890 - $64,730	-1,000 Reduced 22.44%	3,457 $200,000
Q2 2023 Aug 01, 2023	SELL	$63.71 - $70.74 $26,821 - $29,781	-421 Reduced 8.63%	4,457 $285,000
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $46,566 - $55,141	-680 Reduced 12.23%	4,878 $350,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $138 - $82,141	1,069 Added 23.81%	5,558 $385,000

Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $40,667 - $44,788	-560 Reduced 11.09%	4,489 $346,000
Q1 2021 Apr 16, 2021	BUY	$59.34 - $66.74 $12,580 - $14,148	212 Added 4.38%	5,049 $319,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $43,709 - $49,530	757 Added 18.55%	4,837 $300,000
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $402 - $445	7 Added 0.17%	4,080 $246,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $15,952 - $18,650	-291 Reduced 6.67%	4,073 $239,000
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $278 - $404	6 Added 0.14%	4,364 $243,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $214,457 - $279,740	4,358 New	4,358 $280,000

2,499

1.49B

25.9M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $90.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Advisors, LLC with notifications on news.